Exploring Biomarkers in Hereditary Transthyretin Amyloidosis (ELBA)
Hereditary Transthyretin Amyloidosis
About this trial
This is an interventional diagnostic trial for Hereditary Transthyretin Amyloidosis focused on measuring hereditary transthyretin amyloidosis, neurogenetics, neuromuscular disorders, biomarkers, mitochondrial dysfunction
Eligibility Criteria
Inclusion Criteria: Molecularly defined patients with hereditary transthyretin amyloidosis, carrying TTR pathogenic variants Presymptomatic carriers of the pathogenic variants in TTR gene Subjects aged 18 years or older Evidence of a personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study Exclusion Criteria: Inability to understand or unwilling to follow the study requirements including attendance at the study center, completion of questionnaires and participation in laboratory testing as called for by the protocol Inability to sign an informed consent Severe psychiatric diseases
Sites / Locations
- Fondazione Policlinico Universitario Agostino Gemelli IRCCSRecruiting
Arms of the Study
Arm 1
Experimental
Assessment of disease biomarkers